IGC Pharma Files 8-K: Material Agreement & Exhibits
Ticker: IGC · Form: 8-K · Filed: Oct 1, 2025 · CIK: 1326205
| Field | Detail |
|---|---|
| Company | Igc Pharma, Inc. (IGC) |
| Form Type | 8-K |
| Filed Date | Oct 1, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $2.7 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, filing, exhibits
TL;DR
IGC Pharma just filed an 8-K for a new material agreement. Big news pending.
AI Summary
On October 1, 2025, IGC Pharma, Inc. filed an 8-K report. The filing indicates an entry into a material definitive agreement and includes financial statements and exhibits. The company, formerly known as India Globalization Capital, Inc., is incorporated in Maryland and operates in the pharmaceutical preparations sector.
Why It Matters
This 8-K filing signals a significant new agreement for IGC Pharma, Inc., which could impact its business operations and financial standing.
Risk Assessment
Risk Level: medium — 8-K filings often contain material information that can lead to significant stock price volatility.
Key Numbers
- 001-32830 — SEC File Number (Identifies the company's filing with the SEC)
- 20-2760393 — IRS Employer Identification No. (Tax identification number for the company)
Key Players & Entities
- IGC Pharma, Inc. (company) — Registrant
- India Globalization Capital, Inc. (company) — Former company name
- October 1, 2025 (date) — Date of earliest event reported
- Maryland (jurisdiction) — State of incorporation
- 2834 (sic_code) — Standard Industrial Classification for Pharmaceutical Preparations
FAQ
What is the nature of the material definitive agreement entered into by IGC Pharma, Inc. on October 1, 2025?
The filing indicates an entry into a material definitive agreement, but the specific details of the agreement are not provided in the summary information.
What are the key items included in this 8-K filing?
This 8-K filing includes information regarding the entry into a material definitive agreement and financial statements and exhibits.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on October 1, 2025.
What was IGC Pharma, Inc. formerly known as?
IGC Pharma, Inc. was formerly known as India Globalization Capital, Inc.
In which state is IGC Pharma, Inc. incorporated?
IGC Pharma, Inc. is incorporated in Maryland.
Filing Stats: 652 words · 3 min read · ~2 pages · Grade level 12.4 · Accepted 2025-10-01 16:40:35
Key Financial Figures
- $2.7 million — agreed on a fair value of approximately $2.7 million for the transaction, which may be adjus
Filing Documents
- igc8k100125.htm (8-K) — 34KB
- igcex10-1.htm (EX-10.1) — 36KB
- image_001.jpg (GRAPHIC) — 2KB
- 0001185185-25-001326.txt ( ) — 244KB
- igc-20251001.xsd (EX-101.SCH) — 3KB
- igc-20251001_lab.xml (EX-101.LAB) — 33KB
- igc-20251001_pre.xml (EX-101.PRE) — 22KB
- igc8k100125_htm.xml (XML) — 3KB
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits (d) Exhibit No. Description 10.1 Sale of Assets and Manufacturing Agreement, dated September 29, 2025, by and between Holi Hemp LLC and Wellness Northwest Inc. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). The exhibits listed in the following Exhibit Index are filed as part of this current report. 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. IGC PHARMA, INC. Dated: October 1, 2025 By: /s/ Claudia Grimaldi Name: Claudia Grimaldi Title: Principal Financial Officer and Vice President 2